MaximilianSchott

Associate

Munich + 49.89.20.60.42.200

Maximilian Schott advises industrial corporate clients, financial sponsors, and emerging technology companies on complex domestic and cross-border M&A projects, corporate restructurings, as well as on private equity and venture capital transactions. In addition, Maximilian has significant experience in advising investors on acquisitions, disposals, and refinancing of complex real estate and infrastructure projects. He regularly advises clients across the tech, automotive, energy, chemical, industrial, pharma, and health care industries.

Recently, Maximilian advised, inter alia, Suez on the sale of its recycling and recovery operations to the Schwarz Group based on an enterprise value of €1.1 billion, Steris on its acquisition of Cantel Medical for $3.6 billion and of Key Surgical for $850 million, Solvay in the sale of its percarbonate business to Latour Capital, as well as Atlas Arteria on the refinancing of the Warnow tunnel in Rostock with a total deal value of €157 million.

Prior to joining Jones Day, Maximilian practiced at a boutique law firm in Munich, where he advised growth companies and investors on private equity and venture capital transactions, corporate restructurings, and governance matters. During this time he represented, among others, German unicorns Delivery Hero and GetYourGuide on financing rounds and acquisitions.

Maximilian is the founder of the Hans-Jürgen Papier Inn of the International Legal Honor Society of Phi Delta Phi in Munich, a nonprofit organization with more than 200,000 members promoting legal ethics in society around the world. He also serves as province president of Phi Delta Phi in Europe.

Experience

  • Riverside and Investcorp sell Arrowhead Engineered Products to GenstarJones Day advised The Riverside Company in the sale of Arrowhead Engineered Products to Genstar.
  • EMERAM Capital Partners sells portfolio company MEONA to Trill ImpactJones Day represented EMERAM Capital Partners GmbH, one of the leading investment companies for medium-sized companies in the German-speaking region, in the sale of its portfolio company MEONA, an innovation leader for clinical software, to the private equity firm, Trill Impact.
  • STERIS acquires Cantel Medical for $3.6 billionJones Day advised STERIS plc in its acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers, for $3.6 billion.
  • SUEZ sells its SUEZ Recycling & Recovery operations to PreZeroJones Day advised the French listed company SUEZ SA in its largest sale of SUEZ Recycling & Recovery operations - excluding plastic recycling and hazardous waste treatment activities - in four continental Europe countries: the Netherlands, Luxembourg, Germany, and Poland to PreZero, the environmental division of Schwarz Group.
  • Atlas Arteria establishes new capital structure for Warnow Tunnel in GermanyJones Day advised Atlas Arteria, a global owner, operator, and developer of toll roads, on a new approximately 29-year debt facility for its Warnow Tunnel in Germany as part of a capital restructuring.
  • Solvay sells barium, strontium and sodium percarbonate businesses to Latour CapitalJones Day advised Solvay S.A., a publicly listed chemical company based in Brussels, Belgium, on the combined sale of its technical-grade barium and strontium business in Germany, Spain and Mexico, and its sodium percarbonate business in Germany to Latour Capital.
  • Wellington Partners, MIG GmbH & Co. Fonds 16, and Salvia GmbH invest €15 million in growth financing of Creative BalloonsJones Day represented Wellington Partners Life Sciences V, a leading European Venture Capital firm investing in early- and growth-stage Life Science companies, together with MIG GmbH & Co. Fonds 16 and Salvia GmbH, in connection with their €15 million growth investment in Creative Balloons GmbH, a specialist in researching and developing ultra-thin polyurethane (PUR) balloons for medical device applications, namely catheter manufacturing.
  • Verint Systems separates into two independent companiesJones Day advised Verint® Systems Inc. ("Verint") in the separation and spin-off of its cyber intelligence business, Cognyte Systems Ltd.
  • STERIS acquires Key Surgical for approximately $850 millionJones Day advised STERIS plc (NYSE: STE) in the $850 million acquisition of Key Surgical, a leading global provider of sterile processing, operating room, and endoscopy products, and a portfolio company of Water Street Healthcare Partners, LLC.
  • Guardian Europe S.à r.l. sold Guardian Automotive glass business to PARTER Capital Group AGJones Day advised Guardian Europe S.à r.l., a subsidiary of Koch Industries, Inc., in the sale of its Guardian Automotive aftermarket glass fabrication and distribution business to PARTER Capital Group AG.